Funding for vaccine development

UK researchers creating new vaccines for epidemic diseases such as Zika and Ebola are among the winners of £22 million of funding, announced by the Department of Health.

The funding is being shared among 26 vaccine development projects. These projects are among the first to benefit from the UK Vaccine Network £120 million fund, established to support Britain’s role fighting deadly diseases.

As part of the fund, the Department is also launching a further two competitions, worth £60 million, to give academics and scientists the opportunity to apply for financial support. This scale of investment means the UK is the second largest funder of research in this field.

The money supports targeted investments in vaccines for diseases with epidemic potential including projects working to prevent Ebola, Zika and Crimean-Congo Haemorrhagic Fever. The Government is also supporting four projects – worth £2.4 million combined – to develop successful prevention vaccines for diseases which are bioterror threats, such as Plague and Q Fever.



Other news

Upcoming Events

AfPP annual residential conference 2017

University of York
10th - 12th August

NPAG - Clinical Engineering and IT Connectivity Conference 2017

Ricoh Arena - Coventry
12th September 2017

Infection Prevention 2017

Manchester Central Convention Complex
18th - 20th September

QIST 2017

The Marriott Hotel Gosforth Newcastle
17th - 18th October


13 - 16 November 2017

Latest Issue

Clinical Services Journal

Clinical Services Journal

Jun 2017

Providing an insight into patient experience

Register now to apply for regular copies of Clinical Services Journal and free access to premium content, as well as our regular newsletters.